References
- 1. Alekseev NA. Anemia. SPb Hippocrates; 2004: 512.
- 2. Jones JA. Red blood cell substitutes: current status. Br J Anaesth. 1995;74(6):697-703.7640127
- 3. Rentko VT. Red blood cell substitutes. Probl Vet Med. 1992;4(4):647-51.
- 4. Marchbank A. Fluorocarbon emulsions. Perfusion. 1995;10(2):67-88.764738010.1177/026765919501000203
- 5. Michael D. Manual of Canine and Feline Haematology and Transfusion Medicine. Lookers, Upton, Poole, Dorset; 2000: 62‒98.
- 6. Chandler EA, Gaskell CJ. Feline Medicine and Therapeutics. Aquarium; 2002; 696.
- 7. Rosen AL, Gould SA, Sehgal LR, Levine EA, Sehgal HL, Goldwasser E, Beaver CW, Moss GS. Erythropoietic response to acute anemia. Crit Care Med. 1990;18(3):298-302.168923610.1097/00003246-199003000-00011
- 8. Authement JM, Wolfsheimer KJ, Catchings S. Canine blood component therapy: product preparation, storage, and administration. Journal of the American Animal Hospital Association; 1987: (23)483‒493.
- 9. Bell К, Agar PG. Red Blood Cells of Domestic Mammals. Elsevier Science Publishers; 1983:163‒164.
- 10. Clark-Price S. Practical uses of pulse oximeter and capnography. In: Proceedings of 15th IVECCS; 2009: 323‒325.
- 11. Spiess BD. Military Supplement: Perfluorocarbon Emulsions, Platelet Counts and Inflammation. Shock. 2018; doi: 10.1097/SHK.0000000000001154.10.1097/SHK.0000000000001154
- 12. Figueroa MS, Casas DR. Inflammation induced by perfluorocarbon liquid: intra- and postoperative use. Biomed Res Int. 2014; 2014:907816.
- 13. Ma M, Xu H, Chen H, Jia X, Zhang K, Wang Q, Zheng S, Wu R, Yao M, Cai X, Li F, Shi J. A drug-perfluorocarbon nanoemulsion with an ultrathin silica coating for the synergistic effect of chemotherapy and ablation by high-intensity focused ultrasound. Adv Mater. 2014; 26(43):7378-85.
- 14. Forgiarini LA Jr, Forgiarini LF, da Rosa DP, Mariano R, Ulbrich JM, Andrade CF. Endobronchial perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion. J Surg Res. 2013; 183(2):835-40.
- 15. Cronin WA, Senese AL, Arnaud FG, Regis DP, Auker CR, Mahon RT. The effect of the perfluorocarbon emulsion Oxycyte on platelet count and function in the treatment of decompression sickness in a swine model. Blood Coagul Fibrinolysis. 2016; 27(6):702-10.
- 16. Randsøe T. Effect of metabolic gases and water vapor, perfluorocarbon emulsions, and nitric oxide on tissue bubbles during decompression sickness. Dan Med J. 2016;63(5).
- 17. Chang ET, Adami HO, Boffetta P, Wedner HJ, Mandel JS. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Crit Rev Toxicol. 2016; 46(4):279-331.10.3109/10408444.2015.1122573
- 18. Heilmann C, Jensen L, Weihe P, Nielsen F, Knudsen LE, Budtz-Jørgensen E, Mølbak K, Grandjean P. Persistant perfluorinated compounds cause immunotoxic effects. Ugeskr Laeger. 2014;176(9A):V09130572.
- 19. Cabrales P, Carlos Briceño J. Delaying blood transfusion in experimental acute anemia with a perfluorocarbon emulsion. Anesthesiology. 2011; 114(4):901-11.
- 20. Lundgren CE, Bergoe GW, Tyssebotn IM. Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artif Cells Blood Substit Immobil Biotechnol. 2006; 34(5):473-86.
- 21. Habler O, Kleen M, Hutter J, Podtschaske A, Tiede M, Kemming G, Welte M, Corso C, Batra S, Keipert P, Faithfull S, Messmer K. IV perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function. Res Exp Med (Berl). 1998;197(6):301-18.
- 22. Habler OP, Kleen MS, Hutter JW, Podtschaske AH, Tiede M, Kemming GI, Welte MV, Corso CO, Batra S, Keipert PE, Faithfull NS, Messmer KF. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion. 1998;38(2):135-44.10.1046/j.1537-2995.1998.38298193095.x